Evaluation of Thalassaemia Screening Tests in the Antenatal and Non-Antenatal Populations in Singapore.
暂无分享,去创建一个
Jia Hui Goh | E. Yap | E. Y. Lee | Shir Ying Lee | Eng Soo Yap | Elaine Yp Lee | Te Chih Liu | Christina Yip | Te-Chih Liu | C. Yip | Shir-Ying Lee | J. Goh
[1] G. Guyatt,et al. Diagnosis of iron-deficiency anemia in the elderly. , 1990, The American journal of medicine.
[2] A. Cao,et al. Hematological phenotype of the double heterozygous state for alpha and beta thalassemia. , 1984, Hemoglobin.
[3] D. Higgs,et al. Clinical and laboratory features of a-thalassemia syndromes , 2001 .
[4] A. A. Abu Shahla,et al. The effect of iron deficiency anaemia on the levels of haemoglobin subtypes: possible consequences for clinical diagnosis. , 2002, Clinical and laboratory haematology.
[5] Dina N. Greene,et al. Comparison of Sebia Capillarys Flex capillary electrophoresis with the BioRad Variant II high pressure liquid chromatography in the evaluation of hemoglobinopathies. , 2012, Clinica chimica acta; international journal of clinical chemistry.
[6] M. Chee,et al. The simultaneous presence of alpha- and beta-thalassaemia alleles: a pitfall of thalassaemia screening. , 2003, Community genetics.
[7] Joo-In Park,et al. Comparison of Capillary Electrophoresis with Cellulose Acetate Electrophoresis for the Screening of Hemoglobinopathies , 2011, The Korean journal of laboratory medicine.
[8] B. Bain,et al. Significant haemoglobinopathies: guidelines for screening and diagnosis , 2010, British journal of haematology.
[9] B. Bain. Haemoglobinopathy diagnosis: algorithms, lessons and pitfalls. , 2011, Blood reviews.
[10] S. Chong,et al. First successful preimplantation genetic diagnosis in Singapore--avoidance of beta-thalassaemia major. , 2009, Annals of the Academy of Medicine, Singapore.
[11] D. Mais,et al. The range of hemoglobin A(2) in hemoglobin E heterozygotes as determined by capillary electrophoresis. , 2009, American journal of clinical pathology.
[12] M. Scott,et al. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. , 1998, Clinical chemistry.
[13] Committee Opinion No. 691: Carrier Screening for Genetic Conditions. , 2017, Obstetrics and gynecology.
[14] G. Gibney,et al. Is HbA2 level a reliable diagnostic measurement for β‐thalassemia trait in people with iron deficiency? , 2012, American journal of hematology.
[15] T. Bradley,et al. Hemoglobin Gun Hill: an unstable protein associated with chronic hemolysis. , 1968, Blood.
[16] Quah Thuan Chong,et al. A Molecular Epidemiologic Study of Thalassemia Using Newborns' Cord Blood in a Multiracial Asian Population in Singapore: Results and Recommendations for a Population Screening Program , 2004, Journal of pediatric hematology/oncology.
[17] D. Higgs,et al. Single-tube multiplex-PCR screen for common deletional determinants of α-thalassemia , 2000 .
[18] A. Maggio,et al. Iron deficiency does not compromise the diagnosis of high HbA2 β thalassemia trait , 2012, Haematologica.
[19] Jones Alana K Bergstrome,et al. Evaluation of a single-tube multiplex polymerase chain reaction screen for detection of common alpha-thalassemia genotypes in a clinical laboratory. , 2002, American journal of clinical pathology.
[20] C. Hoppe. Prenatal and newborn screening for hemoglobinopathies , 2013, International journal of laboratory hematology.
[21] C. Liao,et al. Detection of alpha-thalassemia in beta-thalassemia carriers and prevention of Hb Bart's hydrops fetalis through prenatal screening. , 2006, Haematologica.
[22] J. Biggio,et al. Committee Opinion No. 691 Summary: Carrier Screening for Genetic Conditions. , 2017, Obstetrics and gynecology.
[23] B. Bain,et al. Capillary zone electrophoresis for haemoglobinopathy diagnosis , 2012, Journal of Clinical Pathology.
[24] D. Chui. α‐Thalassemia: Hb H Disease and Hb Barts Hydrops Fetalis , 2005, Annals of the New York Academy of Sciences.
[25] Y. Lau,et al. Should we screen for globin gene mutations in blood samples with mean corpuscular volume (MCV) greater than 80 fL in areas with a high prevalence of thalassaemia? , 2001, Journal of clinical pathology.
[26] D. Chitayat,et al. Carrier screening for thalassemia and hemoglobinopathies in Canada. , 2008, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.
[27] Bernadette Modell,et al. Prevention of Thalassaemias and Other Haemoglobin Disorders , 2013 .
[28] D. Sabath. Molecular Diagnosis of Thalassemias and Hemoglobinopathies: An ACLPS Critical Review , 2017, American journal of clinical pathology.
[29] L. Chan,et al. Comparison of the HbH inclusion test and a PCR test in routine screening for alpha thalassaemia in Hong Kong. , 1996, Journal of clinical pathology.
[30] V. Viprakasit,et al. Problems in determining thalassemia carrier status in a program for prevention and control of severe thalassemia syndromes: a lesson from Thailand , 2013, Clinical chemistry and laboratory medicine.
[31] A. Barrett,et al. Thalassaemia screening and confirmation of carriers in parents. , 2017, Best practice & research. Clinical obstetrics & gynaecology.
[32] A. García-Raso,et al. Cut-Off Values of Hematologic Parameters to Predict the Number of Alpha Genes Deleted in Subjects with Deletional Alpha Thalassemia , 2017, International journal of molecular sciences.
[33] T. Tongsong,et al. Sensitivity and specificity of mean corpuscular volume testing for screening for alpha-thalassemia-1 and beta-thalassemia traits. , 2005, The journal of obstetrics and gynaecology research.
[34] U. Baylan,et al. Evaluating five dedicated automatic devices for haemoglobinopathy diagnostics in multi‐ethnic populations , 2009, International journal of laboratory hematology.